Seventure Partners targets the microbiome revolution

Eric de la Fortelle, venture partner with Seventure Partners in charge of investments in the Benelux, Scandinavia, Northern Switzerland and North America speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the VC's new fund that focuses on the microbiome revolution. Seventure Partners closed the final round of its EUR 160 million Health for Life Capital vehicle, the world’s first investment fund aimed at health and nutrition, in December 2015. Seventure, a subsidiary of Natixis Global Asset Management, has four areas of focus in life sciences including biotechnology and pharmaceuticals, connected health and medtech, industrial biotechnology, and the microbiome comprising nutrition, foodtech and personalized medicine.

Interviewer: Mike Ward – Global Director of Content, Pharma Intelligence, In Vivo/Pink Sheet/Scrip
Interviewee: Eric de la Fortelle – Venture Partner, Seventure Partners